In January 2018, Menlo Therapeutics went public issuing over 8,000,000 shares of common stock at a public offering price of $17.00 raising over 125 million dollars. NASDAQ lists Menlo’s stock under the ticker symbol “MNLO.” Jefferies LLC, Piper Jaffray & Co. and Guggenheim Securities served as the lead underwriters. Menlo’s…
Updated: